PRE-Symptomatic Studies in Amyotrophic Lateral Sclerosis
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Neurology |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 6/21/2018 |
| Start Date: | November 2013 |
| End Date: | December 2027 |
The goal of PRESS-ALS is to study the earliest manifestations of disease in people with early
ALS in whom some areas of the body are not yet affected.
ALS in whom some areas of the body are not yet affected.
Inclusion Criteria
ALS group:
- Subject is a male or female, aged at least 18 years.
- Subject is affected with ALS (familial or sporadic).
- Subject has at least one limb in which there is no symptomatic upper and lower motor
neuron dysfunction.
- Subject is willing and able to comply with all study procedures.
- Subject agrees to provide signed and dated informed consent form.
Control group:
- Subject is a male or female, aged at least 18 years.
- Subject is not affected with ALS or an ALS-related disorder.
- Subject does not have a family history (i.e., at least 2 biological relatives) of ALS
or an ALS-related disorder.
- Subject is willing and able to comply with all study procedures.
- Subject agrees to provide signed and dated informed consent form.
Exclusion Criterion
• Any condition or situation which, in the PI's opinion, could confound the biomarker data
or may interfere significantly with the individual's participation and compliance with the
study protocol, including but not limited to neurological, psychological and/or medical
conditions (e.g., multiple sclerosis, neuropathy, myelopathy).
We found this trial at
1
site
University of Miami A private research university with more than 15,000 students from around the...
Click here to add this to my saved trials
